See more : SoftTech Engineers Limited (SOFTTECH.NS) Income Statement Analysis – Financial Results
Complete financial analysis of NovelStem International Corp. (NSTM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NovelStem International Corp., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- SkyCity Entertainment Group Limited (SKC.NZ) Income Statement Analysis – Financial Results
- Costco Wholesale Corporation (COST) Income Statement Analysis – Financial Results
- Capri Global Capital Limited (CGCL.NS) Income Statement Analysis – Financial Results
- Pharmicell Co., Ltd. (005690.KS) Income Statement Analysis – Financial Results
- Sri Havisha Hospitality and Infrastructure Limited (HAVISHA.BO) Income Statement Analysis – Financial Results
NovelStem International Corp. (NSTM)
About NovelStem International Corp.
NovelStem International Corp. focuses on developing and commercialization of diagnostic technology for cancer treatments and the potential to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was founded in 1993 and is headquartered in Boca Raton, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.00K | 12.00K | 0.00 | 0.00 | 424.75K | 616.34K | 3.77M | 4.00M | 103.38M | 117.06M | 123.88M | 115.90M | 95.61M | 72.98M | 64.86M | 58.24M | 50.15M | 29.52M | 10.10M | 11.10M | 10.50M | 7.60M | 6.30M | 1.50M | 100.00K |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 2.13M | 3.33K | 4.11M | 5.34M | 81.01M | 92.88M | 93.37M | 81.93M | 67.52M | 56.92M | 50.20M | 41.06M | 32.32M | 14.05M | 3.10M | 4.40M | 4.70M | 4.90M | 5.20M | 1.00M | 0.00 |
| Gross Profit | 12.00K | 12.00K | 0.00 | 0.00 | -1.70M | 613.01K | -335.72K | -1.35M | 22.36M | 24.18M | 30.51M | 33.97M | 28.10M | 16.06M | 14.66M | 17.18M | 17.83M | 15.47M | 7.00M | 6.70M | 5.80M | 2.70M | 1.10M | 500.00K | 100.00K |
| Gross Profit Ratio | 100.00% | 100.00% | 0.00% | 0.00% | -400.45% | 99.46% | -8.91% | -33.67% | 21.63% | 20.65% | 24.63% | 29.31% | 29.39% | 22.01% | 22.61% | 29.50% | 35.56% | 52.40% | 69.31% | 60.36% | 55.24% | 35.53% | 17.46% | 33.33% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 639.87K | 2.35M | 2.64M | 2.57M | 3.32M | 6.29M | 7.20M | 5.89M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 665.28K | 434.43K | 495.54K | 150.71K | 0.00 | 5.54M | 7.23M | 8.48M | 21.40M | 27.22M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 79.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 665.28K | 434.43K | 495.54K | 230.30K | 3.19M | 5.54M | 7.23M | 8.48M | 21.40M | 27.22M | 32.39M | 31.19M | 28.68M | 23.75M | 18.71M | 24.84M | 24.12M | 32.63M | 21.70M | 13.00M | 10.90M | 8.80M | 8.50M | 6.40M | 900.00K |
| Other Expenses | 2.87M | 0.00 | 0.00 | 0.00 | 0.00 | 136.44K | 245.17K | 541.33K | 1.59M | 2.22M | 1.85M | 1.88M | 2.41M | 2.26M | 3.51M | 72.26M | 36.46M | 35.56M | 5.70M | 1.70M | 1.30M | 1.10M | 900.00K | 200.00K | 0.00 |
| Operating Expenses | 3.54M | 434.43K | 495.54K | 561.95K | 3.19M | 6.32M | 9.82M | 11.66M | 25.56M | 32.77M | 40.53M | 40.27M | 36.98M | 26.01M | 22.22M | 97.09M | 60.59M | 68.18M | 27.40M | 14.70M | 12.20M | 9.90M | 9.40M | 6.60M | 900.00K |
| Cost & Expenses | 3.54M | 434.43K | 495.54K | 561.95K | 5.31M | 6.32M | 9.82M | 11.66M | 106.58M | 125.65M | 133.89M | 122.20M | 104.50M | 82.93M | 72.41M | 138.15M | 92.91M | 82.23M | 30.50M | 19.10M | 16.90M | 14.80M | 14.60M | 7.60M | 900.00K |
| Interest Income | 0.00 | 0.00 | 6.83 | 16.51 | 1.18M | 1.25M | 1.04M | 64.92K | 28.92K | 425.25K | 199.44K | 0.00 | 0.00 | 0.00 | 0.00 | 21.76K | 115.93K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 99.02K | 11.02K | 6.83K | 0.00 | 0.00 | 1.25M | 1.04M | 64.92K | 28.92K | 425.25K | 11.60M | 1.79M | 552.84K | 2.61M | 1.44M | 1.29M | 260.22K | 339.52K | 0.00 | 800.00K | 0.00 | 200.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | -260.00K | 732.43K | 495.54K | 230.30K | 73.17K | 136.44K | 245.17K | 541.33K | 1.59M | 2.22M | 3.12M | 4.18M | 3.53M | 4.17M | 4.66M | 16.58M | 36.92M | 35.56M | 5.70M | 1.70M | 1.30M | 1.10M | 900.00K | 200.00K | -100.00K |
| EBITDA | -3.79M | -422.43K | 0.00 | 0.00 | 6.53M | -4.27M | -5.61M | -7.12M | -4.65M | -6.37M | -6.89M | -4.55M | -8.81M | -6.56M | -4.06M | -64.26M | -5.83M | -17.16M | -14.70M | -6.30M | -5.30M | -6.10M | -7.40M | -5.90M | -800.00K |
| EBITDA Ratio | -31,548.33% | -3,520.28% | 0.00% | 0.00% | -1,133.41% | -933.34% | -81.04% | -178.44% | -1.48% | -2.47% | -5.51% | -2.39% | -5.77% | -8.99% | -6.26% | -8.85% | -11.94% | -63.61% | -111.88% | -54.95% | -75.24% | -81.58% | -117.46% | -413.33% | -800.00% |
| Operating Income | -3.53M | -422.43K | -495.54K | -230.30K | -4.89M | -5.70M | -6.05M | -7.66M | -3.20M | -12.11M | -10.01M | -6.31M | -8.88M | -9.95M | -7.56M | -79.91M | -42.75M | -52.71M | -20.40M | -8.00M | -6.40M | -7.20M | -8.30M | -6.10M | -800.00K |
| Operating Income Ratio | -29,381.66% | -3,520.28% | 0.00% | 0.00% | -1,150.64% | -925.21% | -160.57% | -191.83% | -3.09% | -10.35% | -8.08% | -5.44% | -9.29% | -13.64% | -11.65% | -137.22% | -85.24% | -178.59% | -201.98% | -72.07% | -60.95% | -94.74% | -131.75% | -406.67% | -800.00% |
| Total Other Income/Expenses | -359.02K | -11.02K | -6.83K | -315.14K | 11.34M | 1.29M | -1.13M | 836.24K | 1.77M | -2.32M | 144.61K | -1.13M | 2.27M | 1.35M | 2.12M | -57.63M | 1.62M | 1.62M | -3.40M | -1.30M | 2.20M | 100.00K | -100.00K | 300.00K | -100.00K |
| Income Before Tax | -3.88M | -433.45K | -502.36K | -545.44K | 6.45M | -4.41M | -7.17M | -6.83M | -5.62M | -16.86M | -9.87M | 9.52M | -8.91M | -11.60M | -7.44M | -81.55M | -41.83M | -51.85M | -24.70M | -9.30M | -4.40M | -6.70M | -8.40M | -5.90M | -900.00K |
| Income Before Tax Ratio | -32,373.52% | -3,612.10% | 0.00% | 0.00% | 1,519.43% | -715.19% | -190.22% | -170.90% | -5.44% | -14.40% | -7.97% | 8.22% | -9.32% | -15.89% | -11.47% | -140.03% | -83.40% | -175.65% | -244.55% | -83.78% | -41.90% | -88.16% | -133.33% | -393.33% | -900.00% |
| Income Tax Expense | 302.48K | 332.28K | 850.09K | -315.14 | 200.97K | -5.33M | 130.57K | 283.76K | 5.62M | 16.86M | -11.60M | -9.52M | 8.91M | 11.60M | 7.44M | 81.55M | 41.83M | 51.85M | 24.70M | 1.40M | -1.40M | 6.70M | 8.40M | 5.90M | 900.00K |
| Net Income | -4.19M | -765.73K | -1.35M | -545.44K | 6.25M | 10.41M | -6.86M | 4.91M | -5.62M | -16.86M | 1.73M | 9.52M | -8.91M | -11.60M | -7.44M | -81.55M | -41.83M | -51.85M | -24.70M | -10.70M | -3.00M | -6.70M | -8.40M | -5.90M | -900.00K |
| Net Income Ratio | -34,894.17% | -6,381.08% | 0.00% | 0.00% | 1,472.12% | 1,688.94% | -182.04% | 122.79% | -5.44% | -14.40% | 1.40% | 8.22% | -9.32% | -15.89% | -11.47% | -140.03% | -83.40% | -175.65% | -244.55% | -96.40% | -28.57% | -88.16% | -133.33% | -393.33% | -900.00% |
| EPS | -0.09 | -0.02 | -0.03 | -0.01 | 0.28 | 0.45 | -0.28 | 0.16 | -0.18 | -0.53 | 0.05 | 0.29 | -0.28 | -0.42 | -0.36 | -3.19 | -1.61 | -2.23 | -2.01 | -1.43 | -0.51 | -1.22 | -1.95 | -1.49 | -0.36 |
| EPS Diluted | -0.09 | -0.02 | -0.03 | -0.01 | 0.28 | 0.45 | -0.28 | 0.16 | -0.18 | -0.53 | 0.05 | 0.29 | -0.28 | -0.42 | -0.36 | -3.19 | -1.61 | -2.23 | -2.01 | -1.43 | -0.51 | -1.22 | -1.95 | -1.49 | -0.36 |
| Weighted Avg Shares Out | 46.88M | 46.88M | 44.26M | 40.99M | 22.65M | 23.18M | 24.38M | 30.94M | 30.58M | 31.79M | 33.30M | 32.76M | 31.47M | 27.78M | 20.83M | 25.54M | 26.06M | 23.27M | 12.31M | 7.46M | 5.88M | 5.48M | 4.31M | 3.96M | 2.50M |
| Weighted Avg Shares Out (Dil) | 46.88M | 46.88M | 44.26M | 40.99M | 22.65M | 23.18M | 24.38M | 30.94M | 30.58M | 31.79M | 33.30M | 32.76M | 31.47M | 27.78M | 20.83M | 25.54M | 26.06M | 23.27M | 12.31M | 7.46M | 5.88M | 5.48M | 4.31M | 3.96M | 2.50M |
Arbitration Confirms NovelStem Joint Venture's Rights to Exploit 'Tom Clancy's Net Force' Franchise Globally via Film, TV, Online, Streaming, Gaming and Merchandising
Boca Raton, Florida--(Newsfile Corp. - July 13, 2023) - NovelStem International Corp. (OTC Pink: NSTM ) announced today that an Arbitrator has confirmed Netco Partners' rights to broadly license the "Net Force" concept with the Tom Clancy name as a possessory...
Source: https://incomestatements.info
Category: Stock Reports